Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Cancer Screening Access topic
No spam. Unsubscribe anytime.
Committee advances bill to codify Medicaid coverage for evidence-based cancer screenings
Summary
Assembly Bill 234 would codify in state statute the coverage of evidence-based cancer screenings (breast, cervical, colorectal, lung, prostate) for Medicaid beneficiaries to align Nevada law with current Medicaid practice and the Affordable Care Act; the committee recommended the bill for passage as part of a consent motion.
Assembly Bill 234 would codify existing Medicaid practices by stating that evidence-based cancer screenings — including breast and cervical screenings explicitly — are protected and covered for Medicaid beneficiaries, Assemblymember Natha Anderson told the Senate Committee on Health and Human Services.
Anderson said the bill’s intent is to ensure parity between Medicaid beneficiaries and other insured Nevadans for evidence-based screenings such as breast, cervical, colorectal, lung and prostate cancer tests. "The early screenings can help prevent this risk of death," Anderson said, citing national estimates of cancer diagnoses and deaths.
The bill’s reprint narrowed the original proposal after sponsors learned that covering some at‑home DNA stool tests (for colorectal screening) would trigger a significant fiscal note; the reprint instead codifies current Medicaid practice and aligns Nevada statute with the federal Affordable Care Act’s preventive-service requirements. Carrie Harrington of the Nevada Cancer Coalition testified in support and noted Medicaid already pays for most recommended screenings; the bill would put that coverage into state code.
Committee members discussed the scope of "screening" language and confirmed it generally follows current practice and USPSTF recommendations; Medicaid staff and coalition representatives said they worked to align statutory language with existing clinical guidance. There was no opposition testimony on the record. After other hearings concluded, the committee placed AB234 on a due-pass consent motion; the motion carried unanimously.
